By Y. Peter Kang ( March 22, 2016, 9:05 PM EDT) -- A California federal jury said Tuesday that two patents held by Merck covering a key ingredient used in Gilead's blockbuster hepatitis C drugs were valid, setting the stage for a potential $2 billion windfall for Merck as the case heads to the damages phase....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.